;

Articles Not Curated - Drug studies in animals
Last updated: 2024 Dec 18
Total hit(s): 1099
S.No.
1
39635731
Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.
Emerg Microbes Infect
2025 Dec
5.84
1
2
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
3
40318419
Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
Virology
2025 Jul
2.819
1
4
40482468
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant.
EBioMedicine
2025 Jun 6
6.49
1
5
40500288
Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2.
NPJ Vaccines
2025 Jun 11
4.98
1
6
40498855
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
Sci Transl Med
2025 Jun 11
11.64
1
7
40254136
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
J Control Release
2025 Jun 10
15.5
1
8
40401447
The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2.
Viral Immunol
2025 Jun
3.4
1
9
40522277
Papain-Like Protease of SARS-CoV-2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors.
J Med Virol
2025 Jun
2.07
1
10
40236291
Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes.
Biochem Biophys Rep
2025 Jun
1.65
1
11
40442985
Pathological Glucose Levels Enhance Entry Factor Expression and Hepatic SARS-CoV-2 Infection.
J Cell Mol Med
2025 Jun
4.59
1
12
40046771
Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct.
J Struct Biol X
2025 Jun
1
13
40349960
Palmitoylated COX-2(Cys555) reprogrammed mitochondrial metabolism in pyroptotic inflammatory injury in patients with post-acute COVID-19 syndrome.
J Adv Res
2025 May 9
1
14
40255103
Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity.
ACS Infect Dis
2025 May 9
4.96
1
15
40335518
Exploring the therapeutic potential of Thymus vulgaris ethanol extract: a computational screening for antimicrobial compounds against COVID-19 induced mucormycosis.
Sci Rep
2025 May 7
4.12
1
16
40447603
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.
Nat Commun
2025 May 30
11.8
1
17
40280285
Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia.
Int J Pharm
2025 May 30
9.5
1
18
40436929
Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike protein.
Sci Rep
2025 May 28
4.12
1
19
40437568
Antimicrobial resistance in the Nordics: mapping existing surveillance systems and assessing the impact of COVID-19 using regression models.
Antimicrob Resist Infect Control
2025 May 28
3.61
1
20
40425664
Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate.
Sci Rep
2025 May 27
4.12
1
21
40392435
A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARS-CoV-2 vaccination.
CEN Case Rep
2025 May 20
1.5
1
22
40383396
Novel coronaviruses identified in livestock: The urgent need to enhance coronavirus surveillance to mitigate zoonotic risks.
J Infect
2025 May 16
5.1
1
23
40379662
Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease.
Nat Commun
2025 May 16
11.8
1
24
40379909
Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection.
AAPS PharmSciTech
2025 May 16
2.451
1
25
40360482
SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform.
Nat Commun
2025 May 14
11.8
1